15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Precigen Inc, 3 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $8.00 to $14.00, a moderate spread. The average target of $11.00 sits 99% above the current $5.53. The rating mix has stayed broadly stable, with Buy-side ratings easing from 4 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.00 next quarter toward $0.20 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy375%
Hold125%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Precigen Inc.
As of Jul, 3 of 4 firms rate PGEN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PGEN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.00
Range $-0.01 – $0.01 · 3 analysts · -100% YoY
Next period, 3 analysts expect Precigen Inc to earn $-0.00 a share (range $-0.01 – $0.01), versus $-1.06 a year earlier. Full-year consensus is $-0.03, growing to $0.20 the year after.
REVENUE · NEXT QUARTER
$33.5M
Range $31.0M – $35.4M · 3 analysts · +1045% YoY
Revenue is expected to reach $33.5M (range $31.0M – $35.4M), +1044.9% year-over-year. Full-year consensus is $124.4M, rising to $229.0M next year.
Top analysts covering Precigen Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PGEN.
#1
Jason Butler
JMP Securities · Rank #22
Buy
$8.00+44.8% to target
Overall win rate
57%
+ Follow
#2
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #230
Buy
$14.00+153.4% to target
Overall win rate
37%
+ Follow
#3
JN
Jason N. Butler
Citizens
Buy
$11.00+99.1% to target
Coverage
—
+ Follow
#4
JK
Jennifer Kim
Cantor Fitzgerald
Buy
No targeton PGEN
Coverage
—
+ Follow
#5
Brian Cheng
JP Morgan
Hold
No targeton PGEN
Coverage
—
+ Follow
PGEN stock forecast FAQ
What is PGEN's average 12-month price target?+
The 3 analysts with a live target average $11.00 for Precigen Inc over the next 12 months, ranging from a $14.00 high to a $8.00 low.
Is PGEN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 3 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PGEN?+
The Street-high target is $14.00 (HC Wainwright & Co.), and the Street-low is $8.00 (JMP Securities). The average of all 3 active targets is $11.00.
How many Wall Street analysts cover PGEN?+
4 analysts have an active rating on Precigen Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering PGEN?+
Among analysts who currently cover PGEN, Jason Butler of JMP Securities has the strongest overall Quantellect track record (Rank #22). Their current call is Buy with a $8.00 target.
What is Precigen Inc's projected EPS for next quarter?+
The consensus estimate is $-0.00 per share (range $-0.01 – $0.01) across 3 analysts. Full-year EPS is projected at $-0.03, rising to $0.20 the following year.
How much revenue is Precigen Inc expected to report next quarter?+
Consensus revenue is $33.5M (range $31.0M – $35.4M). Full-year revenue is projected at $124.4M, growing to $229.0M next year.
Have analysts been upgrading or downgrading PGEN lately?+
As of Jul, 3 of 4 firms rate PGEN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PGEN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
